"Clinical laboratories need automation solutions that combine proven extraction performance with the standardization, traceability and productivity needed for today's molecular testing workflows," ...
QIAmini is the third new QIAGEN sample preparation system launched in 2026. It follows QIAsprint Connect for high-throughput research sample processing and QIAsymphony Connect for medium-throughput ...
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the commercial launch of QIAsymphony Connect, an IVD-compliant platform for automated clinical nucleic acid extraction. Building ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results